Skip to content Home | FAQ's | About Us | Contact Us | Useful Links | Languages | Help | Site Map | Search  
Parkinsons Logo
media & advocacy  
 
About Parkinson's Our Services Research Media & Advocacy How you can help Fundraise & Merchandise Donate
arrow Media & Advocacy
Advocacy
Media Releases
Media Contacts
Key Facts & Figures
In the news
 

In the news

Medication News

Sifrol ER - a new treatment option for people living with Parkinson’s

Parkinson’s Victoria has recently been advised that Sifrol ER - a new 24 hr sustained release tablet form of Sifrol, will become available on the 1st of August 2010 under the Pharmaceutical Benefits Scheme (PBS).

Sifrol ER was given market authorisation in Europe in October 2009, and is now going to be available in Australia under the PBS (the government scheme which subsidises the cost of medications).

In clinical trials that supported the European authorisation, the data showed more constant levels of plasma concentration were achieved with a once a day tablet than with the three times a day immediate release tablet.

The 24 hour release tablet will allow a more constant medication level throughout the 24 hours potentially reducing the severity of motor fluctuations, and for some people improving sleep and assisting with night time difficulties. 

Sifrol ER will become available after the 1st of August 2010. Trials and use in Europe indicate that you are easily able to switch to Sifrol ER overnight from the immediate release tablet taken three times daily. A once a day formulation also has the benefit of reducing the numbers of tablets that are needed in a day.

Sifrol ER has all the same side effects as the other form of Sifrol, with the most common side effect being nausea, constipation, hallucinations, confusion, dizziness and swelling of the feet.

Sifrol ER also has the potential to cause some behavioural change such as compulsive gambling, increased sex drive, compulsive shopping or eating.


MEDIA

'Skin cells used in Parkinson's research' article in the Age - July 2010

This article is on a research project in the UK that is using the skin cells from people with Parkinson's to grow dopamine-producing brain cells.

 Click here to read the article posted on The Age website

 

'Sergey Brin's Search for a Parkinson's Cure' - June 2010

An interesting article on Sergey Brin, the co-founder of Google, about his genetic risk of developing Parkinson's and what he is doing to reduce the odds.

 Click here to read the article posted on the Michael J. Fox Foundation website

 

Deep Brain Surgery segment on TodayTonight - March 2010

Deep brain stimulation (DBS) works by targeting one of several areas in the brain that are part of the movement disorder pathway. By placing a fine wire (electrode) very precisely within the desired area, we are able to introduce a small amount of electrical current to these areas, which causes deactivation of the nerve cells. This segment talks about how DBS is not only an option for Parkinson's Disease, but it is now also being used for treating other neurological conditions.

 Watch the Today Tonight segment on Deep Brain Stimulation

 

John 'Strop' Cornell in the Herald Sun- March 2010

John Cornell ( best known as Paul Hogan's hapless sidekick Strop) underwent Deep Brain Stimulation 5 months ago and tells his story to the Herald Sun about life post-surgery.

Read the Herald Sun article here about John 'Strop' Cornell here

 

Nerissa Mapes in the Woman's Day - December 2007

Nerissa Mapes was diagnosed with Parkinson's at age 28.  Read her story in this article in Woman's Day.

 Click here to read the Woman's Day article  (Use the "Zoom" function to enlarge the article)

 

 

 

Developed by webfuture.com.au
© 2006 Parkinsons Victoria.
Best Viewed at 1024x768 Screen Resolution.

Home | About Us | FAQ's | Contact Us | Privacy Policy | Disclaimer | Help | Site Map | Search
rollover preloadValid HTML 4.01!Valid CSS!